TRDA R&D Expenses
Entrada Therapeutics Inc · R&D Expenses
TRDA R&D Expenses
Latest reported$35.37Mperiod ending
TRDA Quarterly R&D Expenses ($4.37M → $35.37M)
Quarterly R&D Expenses
High-resolution chart · PNG
TRDA r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 35,369,000 | |
| 33,054,000 | |
| 33,957,000 | |
| 38,361,000 | |
| 37,877,000 | |
| 32,074,000 | |
| 33,406,000 | |
| 31,257,000 | |
| 32,035,000 | |
| 28,608,000 | |
| 28,291,000 | |
| 22,191,000 | |
| 26,300,000 | |
| 23,102,000 | |
| 15,685,000 | |
| 18,958,000 | |
| 16,248,000 | |
| 15,718,000 | |
| 12,362,000 | |
| 10,513,000 | |
| 6,829,000 | |
| 6,223,000 | |
| 6,656,000 | |
| 5,700,000 | |
| 4,373,000 | |
| 4,373,000 |